UBS downgraded Salix Pharmaceuticals (NASDAQ: SLXP) from Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Downgrades

Cantor Fitzgerald Downgrades Salix Pharmaceuticals (SLXP) to HoldFebruary 24, 2015 7:23 AM Valeant Pharmaceuticals (VRX) PT Lifted to $210 at Guggenheim Amid Salix DealFebruary 23, 2015 12:00 PM Leerink Swann Downgrades Salix Pharmaceuticals (SLXP) to Market PerformFebruary 23, 2015 7:21 AM Piper Jaffray Downgrades Salix Pharmaceuticals (SLXP) to Neutral Amid TakeoverFebruary 23, 2015 6:39 AM Valeant Pharma (VRX) to Acquire Salix Pharma (SLXP) in $14.5B DealFebruary 22, 2015 4:29 PM Valeant Pharma (VRX) Nears Deal for Salix Pharma (SLXP) - CNBC's FaberFebruary 20, 2015 9:46 AM